EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel injectable polypeptide nanoparticle encapsulated siRNA targeting TGF‐β1 and COX‐2 for localized fat reduction I: Preclinical in vitro and animal models

Mark S Nestor iD, John Hetzel, Nardin Awad, Vishnu Bhupalam, Patrick Lu, Michael Molyneaux

Journal of Cosmetic Dermatology · 2024

DOI: 10.1111/jocd.16535 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cosmetic Dermatology, 2024. Verfasst von Mark S Nestor und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Clinical and Cosmetic Research, Aventura, Florida, USA. Hauptthemen laut MEDLINE: RNA, Small Interfering, Transforming Growth Factor beta1, Nanoparticles, Cyclooxygenase 2. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: sirnaomics, Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Obesity and localized fat accumulation continue to drive the demand for minimally invasive body contouring technologies including injectable compounds for local fat reduction. siRNA offers a potential for an injectable to specifically target and silence genes involved in adipogenesis with minimal inflammatory side effects.

Aims

This study evaluates the efficacy of STP705, an injectable containing siRNA encapsulated within histidine‐lysine polypeptide (HKP) nanoparticles targeting transforming growth factor β1 (TGF‐β1) and cyclooxygenase‐2 (COX‐2), crucial mediators in adipocyte differentiation and fat retention, using in vitro, porcine, and murine models.

Methods

In vitro experiments on mouse preadipocytes and in vivo trials using Diet Induced Obese (DIO) mice and Yucatan minipigs were conducted to assess the gene silencing efficiency, tissue localization, pharmacodynamics, and safety profile of STP705.

Results

STP705 effectively reduced the expression of TGF‐β1 and COX‐2, with a notable decrease in adipocyte volume and lipid content without adverse systemic effects. In DIO mice, the HKP‐siRNA complex demonstrated precise localization to injected adipose tissue, maintaining significant gene silencing, and detectable levels of siRNA for up to 14 days post‐administration. Similar results in minipigs showed a significant reduction in subcutaneous adipose tissue thickness.

Conclusion

The results of these studies support the use of targeted siRNA therapy specifically targeting TGF‐β1 and COX‐2, for localized fat reduction, offering a potential minimally invasive alternative to current fat reduction methods.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Small InterferingTransforming Growth Factor beta1NanoparticlesCyclooxygenase 2Swine, MiniaturePeptidesAdipocytesAnimalsSwineMiceObesityAdipogenesisDisease Models, AnimalGene SilencingSubcutaneous Fat

Stichwörter der Autor:innen

COX‐2TGF‐β1adiposefatsiRNA

Substanzen

RNA, Small InterferingTransforming Growth Factor beta1Cyclooxygenase 2Peptides

Autor:innen und Institutionen

  • Center for Clinical and Cosmetic Research, Aventura, Florida, USA.
  • Department of Dermatology and Cutaneous Surgery, University of Miami, Miller School of Medicine, Miami, Florida, USA.
  • Sirnaomics Inc, Gaithersburg, Maryland, USA.

ORCID-Profile: Mark S Nestor

Förderung

  • sirnaomics, Inc

Zitieren

APA

Nestor, M. S., Hetzel, J., Awad, N., Bhupalam, V., Lu, P., & Molyneaux, M. (2024). Novel injectable polypeptide nanoparticle encapsulated siRNA targeting TGF‐β1 and COX‐2 for localized fat reduction I: Preclinical in vitro and animal models. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.16535

Vancouver

Nestor MS, Hetzel J, Awad N, Bhupalam V, Lu P, Molyneaux M. Novel injectable polypeptide nanoparticle encapsulated siRNA targeting TGF‐β1 and COX‐2 for localized fat reduction I: Preclinical in vitro and animal models. Journal of Cosmetic Dermatology. 2024. doi:10.1111/jocd.16535

BibTeX
@article{Nestor2024,
  author = {Nestor, Mark S and Hetzel, John and Awad, Nardin and Bhupalam, Vishnu and Lu, Patrick and Molyneaux, Michael},
  title = {Novel injectable polypeptide nanoparticle encapsulated siRNA targeting TGF‐β1 and COX‐2 for localized fat reduction I: Preclinical in vitro and animal models},
  journal = {Journal of Cosmetic Dermatology},
  year = {2024},
  doi = {10.1111/jocd.16535}
}
Kostenlos starten →